ArticleTechnology in cancer research & treatment

HER2-Targeted Nanoliposome Therapy Activates Immune Response by Converting Cold to Hot Breast Tumors.

Quan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.